Flagship Pioneering Inc. Kaleido Biosciences, Inc. Transaction History

Flagship Pioneering Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $978,785 - $33.3 Million	-19,575,710 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.2 - $16.82 $1.55 Million - $3.62 Million	215,000 Added 1.11%	19,575,710 $159 Million
Q2 2020 Aug 13, 2020	BUY	$4.62 - $8.01 $9.24 Million - $16 Million	2,000,000 Added 11.52%	19,360,710 $144 Million
Q1 2019 May 14, 2019	BUY	$12.71 - $15.0 $221 Million - $260 Million	17,360,710 New	17,360,710 $252 Million

2.3K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Flagship Pioneering Inc., based on Form 13F filings with the SEC.

Stay updated on Flagship Pioneering Inc. with notifications on news.